Clinical trial
The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
NCT03947879 is registered in ClinicalTrials.gov with Hawaii Pacific Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
- Lead sponsor
- Hawaii Pacific Health
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- May 31, 2019
- Completion date
- May 31, 2022
- Enrollment
- 25 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.